Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Johnston, Edward W.
Text and Data Mining valid from 2020-01-31
Version of Record valid from 2020-01-31
31 October 2019
13 January 2020
31 January 2020
Reto Bale is a consultant for CAScination. All other authors have no conflicts of interest to disclose.